|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/44 | |
| C07D 403/04 | |||
| C07D 405/14 | |||
| C07D 405/04 | |||
| C07D 409/04 | |||
| C07D 413/04 | |||
| C07H 13/10 |
| (11) | Number of the document | 3243515 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17161699.8 |
| Date of filing the European patent application | 2012-08-28 | |
| (97) | Date of publication of the European application | 2017-11-15 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-16 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161528998 P | 2011-08-30 | US |
| (72) |
COURTNEY, Stephen Martin, GB
PRIME, Michael, GB
MITCHELL, William, GB
BROWN, Christopher John, GB
DE AGUIAR PENA, Paula C., GB
JOHNSON, Peter, GB
DOMINGUEZ, Celia, US
TOLEDO-SHERMAN, Leticia M., US
MUNOZ, Ignacio, US
|
| (73) |
CHDI Foundation, Inc.,
350 Seventh Ave Suite 200, New York, NY 10001,
US
|
| (54) | KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF |
| KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF |